title: The role of human adult stem cells and cell-cell communication in cancer chemoprevention and chemotherapy strategies.
abstract: Since carcinogenesis is a multi-stage, multi-mechanism process, involving mutagenic, cell death and epigenetic mechanisms, during the "initiation/promotion/and progression" phases, chemoprevention must be based on understanding the underlying mechanism(s) of each phase, In principle, prevention of each of these phases could reduce the risk to cancer. However, because reducing the mutagenic/initiation phase to a zero level is impossible, the most efficacious intervention would be at the promotion phase that requires a sustained exposure to promoting conditions/agents. In addition, assuming the "target" cells for carcinogenesis are the pluri-potent stem cells and their early progenitor or transit cells, chemoprevention strategies for inhibiting the promotion of these two types of pre-malignant "initiated" cells will require different kinds of agents. A hypothesis will be proposed that involves adult stem cells, which express Oct-4 gene and lack gap junctional intercellular communication (GJIC-) or the early progenitor cells which express GJIC+ and are partially-differentiated, if initiated, will be promoted by agents that either inhibit secreted negative growth regulators or by inhibitors of GJIC. Consequently, anti-tumor promoting chemopreventing agents to each of these two types of initiated cells must have different mechanisms of action and work on different target cells. Assuming stem cells are target cells for carcinogenesis, an alternative method of chemoprevention would be to reduce the stem cell pool. Many classes of anti-tumor promoter chemopreventive agents, such as green tea components, resveratrol, caffeic acid phenethylene ester, either up-regulate GJIC in stem cells or prevent the down regulation of GJIC by tumor promoters in early progenitor cells.
authors.affiliation: 246 National Food Safety Toxicology Center, Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA. james.trosko@ht.msu.edu
authors.forename: James E
authors.initials: JE
authors.lastname: Trosko
authors.forename: Chia-Cheng
authors.initials: CC
authors.lastname: Chang
authors.forename: Brad L
authors.initials: BL
authors.lastname: Upham
authors.forename: Mei-Hui
authors.initials: MH
authors.lastname: Tai
mesh_terms: D000328:Adult; D016588:Anticarcinogenic Agents / Q000378:metabolism*; D002273:Carcinogens / Q000378:metabolism; D002450:Cell Communication / Q000502:physiology*; D002454:Cell Differentiation / Q000502:physiology; D002471:Cell Transformation, Neoplastic; D004358:Drug Therapy; D017629:Gap Junctions / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy; D013234:Stem Cells / Q000502:physiology*
chemical_list: D016588:Anticarcinogenic Agents; D002273:Carcinogens